STOCK TITAN

AMBEV S.A. Form 4 Filings

ABEV NYSE

Every Form 4 that AMBEV S.A. (ABEV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ABEV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ABEV filings page.

Rhea-AI Summary

Ambev S.A. director Ricardo Manuel Frangatos Pires Moreira reported a sale of 468,040 common shares on 2026-07-30 at a weighted average price of $3.08 per share, with individual sale prices between $3.08 and $3.09. After this transaction, he directly holds 3,000,000 common shares, including certain shares represented by American Depositary Shares.

Rhea-AI Summary

AMBEV S.A. officer Paulo Andre Zagman reported an open-market sale of 136,250 common shares on May 5, 2026 at an average price of $3.41 per share. After this transaction, he directly holds 230,535 common shares, which include shares represented by American Depositary Shares.

The reported U.S. dollar price reflects a conversion from Brazilian reais using a foreign exchange rate of BRL 4.92 per $1.00 as of the transaction date.

Rhea-AI Summary

AMBEV S.A. officer Eduardo Braga Cavalcanti de Lacerda reported an open-market sale of 152,386 Common Shares on March 27, 2026 at $2.85 per share. Following this transaction, he directly owns 223,340 Common Shares of the company.

Rhea-AI Summary

Klutzenschell Lisboa Carlos Eduardo reported acquisition or exercise transactions in this Form 4 filing.

AMBEV S.A. Chief Executive Officer Klutzenschell Lisboa Carlos Eduardo received a grant of 205,372 Common Shares on March 30, 2026 as part of a performance-based bonus payment. The shares were valued at $3.11 per share, bringing his direct holdings to 2,001,442 Common Shares after the award.

Rhea-AI Summary

Malik Parente Guilherme reported acquisition or exercise transactions in this Form 4 filing.

AMBEV S.A. officer Malik Parente Guilherme received a grant of 8,455 common shares of the company on March 30, 2026. The shares were awarded at a reference price of $3.11 per share as part of a performance-based bonus payment and are held directly. Following this award, Guilherme directly owns 35,182 common shares of AMBEV S.A.

Rhea-AI Summary

AMBEV S.A. officer Duarte Valdecir received a grant of 38,074 Common Shares on March 30, 2026 as part of a performance-based bonus payment. The grant is recorded at a price of $3.11 per share and is held as direct ownership.

Following this compensation-related acquisition, Valdecir directly holds 743,437 Common Shares of Ambev. This Form 4 reflects an award of shares rather than an open-market purchase or sale.

Rhea-AI Summary

AMBEV S.A. executive Eduardo Braga Cavalcanti de Lacerda received a grant of common shares as part of a performance-based bonus payment. He acquired 30,431 common shares valued at $3.11 per share, increasing his direct holdings to 375,726 common shares. This was a compensation-related award, not an open-market purchase.

Rhea-AI Summary

Crippa Prado Carla Smith de Vasconcellos reported acquisition or exercise transactions in this Form 4 filing.

AMBEV S.A. officer Crippa Prado Carla Smith de Vasconcellos received a grant of 11,261 Common Shares on March 30, 2026 as part of a performance-based bonus payment, valued at $3.11 per share.

After this equity award, her direct holdings increased to 141,464 Common Shares, reflecting routine share-based compensation rather than an open-market transaction.

Rhea-AI Summary

Parolari Guilherme Fleury de Figueiredo Ferraz reported acquisition or exercise transactions in this Form 4 filing.

AMBEV S.A. reported that company officer Parolari Guilherme Fleury de Figueiredo Ferraz received a grant of 44,714 Common Shares on a performance basis. The shares were valued at $3.11 per share for reporting purposes. Following this compensation-related award, his direct holdings increased to 64,607 Common Shares.

Rhea-AI Summary

Zagman Paulo Andre reported acquisition or exercise transactions in this Form 4 filing.

AMBEV S.A. officer Paulo Andre Zagman received a grant of 34,714 common shares of Ambev on March 30, 2026 as part of a performance-based bonus payment. The shares were valued at $3.11 per share, increasing his direct holdings to 366,785 common shares, including shares represented by American Depositary Shares.

Rhea-AI Summary

AMBEV S.A. officer Malik Parente Guilherme reported an open-market sale of 20,971 common shares at a weighted average price of $2.76 per share on March 24, 2026. The shares were sold in multiple trades between $2.76 and $2.81. After this transaction, he directly holds 26,727 common shares.